All News
Patients with RA-ILD vs RA only: More likely to be older, male, white and RF positive. More likely to have COPD, Rheumatoid nodules, erosions, extraarticular disease,⬆️antiCCP,⬆️ESR & ⬆️DAS28(CRP), DAS28(ESR), CDAI & SDAI scores #EULAR2020 #eular20 https://t.co/OhI9NKpStE
Mario Pompermayer, MD pompermarioMD ( View Tweet)
SAPHO or PsA with CASPAR criteria? 1/3 of SAPHO pts meet PsA criteria (particularly active or hx of psoriasis). Interestingly, most with osteitis did not meet CASPAR criteria while those with synovitis did. #EULAR2020 @RheumNow #AB0738 https://t.co/G4p6OiocE3
Dr. Rachel Tate uptoTate ( View Tweet)
Congratulations from all of us at the BRC to Professor Paul Emery OBE for being awarded a Meritorious Award at EULAR 2020 #EULAR2020goesvirtual #EULAR2020 #FightingRMDsTogether https://t.co/z9T4AZ5P0u
NIHR Leeds BRC LeedsBRC ( View Tweet)
Guselkumab improved axial symptoms, over 24 weeks in active PsA patients with radiographic sacroiliitis. Post-hoc analysis from Discover1&2 studies (Prof P Helliwell). #OP0054. #EULAR2020, >GF
ARD & RMD Open ARD_BMJ ( View Tweet)
Can fatigue in RA vary by bDMARD used? IL-6 inhibitor treatment associated with attaining a low fatigue state (RR 1.20 vs csDMARDs).
Given IL-6 secretion with HPA axis activation leads to fatigue/poor sleep, maybe something in this?
RABBIT database OP0020 #EULAR2020 @RheumNow https://t.co/wzFcqdUMMV
David Liew drdavidliew ( View Tweet)
17,500 people connected at moment at the largest e-Congress I could imagine #EULAR2020 #EULAR2020goesvirtual
Loreto Carmona 🖖 carmona_loreto ( View Tweet)
You've got at least two good reasons not to forget about cardiovascular risk in ankylosing spondylitis.
Traditional and inflammatory: it's the double whammy.
Mike Nurmohamed from @Reade_020 #EULAR2020 @RheumNow https://t.co/GLH7wzvrLN
David Liew drdavidliew ( View Tweet)
Use Of TNFi Before, During And The 1stY after Pregnancy Among Women With RA: Most of the women with RA were not treated with TNFi before or in pregnancy. Women w. RA that continue Rx with TNFi through pregnancy were using certilozumab and etanercept #EULAR2020 @RheumNow Abs0302 https://t.co/bWKrpx1hx7
Dr Philip Robinson philipcrobinson ( View Tweet)
Increased cardiovascular risk in:
- AS patients (adj HR 4.6 vs non-rheum controls)
- longer disease duration of inflammatory rheum disease (7% per year)
in a Spanish national multicentre project (CARMA) w 5y follow-up
Martin Martinez OP0002 #EULAR2020 @RheumNow https://t.co/BffbfPfkj0
David Liew drdavidliew ( View Tweet)
Consensus Statement: Use Of Jakinib Therapy In Immune Mediated Inflammatory Diseases: A consensus statement from @drpnash and others. Abstract AB0352. #EULAR2020 @RheumNow https://t.co/5uqwFoUglS https://t.co/fIZPWGHAPx
Links:
Dr Philip Robinson philipcrobinson ( View Tweet)
Certolizumab Pegol: A Safe And Efficient Treatment In Patients With Uveitis During Pregnancy: Conclusion: CZP seems to be effective and safe in female patients with uveitis during pregnancy and neonates. Abstract AB1055 #EULAR2020 @RheumNow https://t.co/MzeZKBawTg
Dr Philip Robinson philipcrobinson ( View Tweet)
Spinal Radiographic Progression in axSpA and the Impact Of Classification As non-radiographic Versus Radiographic Disease => Conclusion: Spinal structural damage is mainly restricted to patients with r-axSpA #OP0075 @XBaraliakos #EULAR2020 @RheumNow https://t.co/VYDwKfT44A https://t.co/G3kCN2ebzW
Links:
Dr Philip Robinson philipcrobinson ( View Tweet)
Population studies show #AS patients have a 36% increased risk of Cardiovascular mortality - most deaths being vascular disease relate #EULAR2020 https://t.co/H3CK81lEOb https://t.co/v6V5HlgRt1
Links:
Dr. John Cush RheumNow ( View Tweet)
46,311 #RA patients from the Swedish Rheumatology Quality Register were assessed for venous thromboembolism (VTE) risk. Increasing Dz activity increased the VTE risk #EULAR2020 OP0034 https://t.co/vEjKMMsT0U https://t.co/rzMMI9PlsV
Links:
Dr. John Cush RheumNow ( View Tweet)
Study of 21,525 RA patients in the Forward Databank finds 13.8% w/ lung disease (LD).RA-LD pts had more hospitalizations/deaths (HR 1.3) and 4 fold risk of resp-related events, not influenced by therapies. #EULAR2020 #OP0039 @RheumNow https://t.co/AgZcljDUDv https://t.co/Hl8Pc0YGnh
Links:
Dr. John Cush RheumNow ( View Tweet)
Case Controlled Study of 482 RA patients with ILD vs 741 RA w/o IL found an inverse relationship Between MTX exposure and ILD #EULAR2020 #OP0036 @RheumNow https://t.co/tfkBr0vyRP
Dr. John Cush RheumNow ( View Tweet)
Slightly crazy to be attending EULAR from my study. But crazy times #EULAR2020 @RheumNow https://t.co/X52Ep09GX4
Dr Philip Robinson philipcrobinson ( View Tweet)
I may not be allowed to go to Frankfurt for EULAR this year - but #EULAR2020 can come to me!
Once again delighted to be tweeting for @RheumNow this meeting, and settling in for a big night in Australia of day 1 #EULAR2020goesvirtual (thanks @eular_org!) https://t.co/Mve8NY7EBn
David Liew drdavidliew ( View Tweet)
Waiting for godot....I mean #EULAR2020 https://t.co/mFP4Lwld4U
Dr. John Cush RheumNow ( View Tweet)
#EULAR2020 is off to a bad start https://t.co/Oc2ysedu4P
Dr. John Cush RheumNow ( View Tweet)